FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Comparison of immunofluorescence and chemiluminescence assay...
Equine veterinary journal2020; 52(5); 709-714; doi: 10.1111/evj.13227

Comparison of immunofluorescence and chemiluminescence assays for measuring ACTH in equine plasma.

Abstract: The chemiluminescence (CL) and immunofluorescence (IF) assays yield different results for basal adrenocorticotropin hormone concentrations [ACTH] in pony plasma. It is unclear whether this difference also occurs in basal samples from horses or samples from ponies following thyrotropin-releasing hormone (TRH) stimulation. Objective: To compare the results of [ACTH] analysis by CL and IF methods in basal samples from horses and pony samples following TRH stimulation. Methods: Method comparison. Methods: Plasma [ACTH] was measured concurrently using CL and IF methods in 12 ponies (basal and post-TRH stimulation) in November and basal samples from horses (n = 45; November and May). Results: CL and IF methods yielded different results (P < .01). The median difference (CL-IF) (95% CI) for ponies was 5.9 (0.1-7.5) pg/mL at baseline and 227.9 (61-1001) pg/mL post TRH; and horses 1.9 (1.1-5.4) pg/mL in November and 9.4 (8.2-11.5) pg/mL in May, at baseline. Correlation was good in ponies at baseline (R = 0.80, P = .003) but not post-TRH, and good in horses in November and May (R = 0.68 and 0.71, P 29 and >110 pg/mL, agreement was moderate (ƙ = 0.67) and very good (ƙ = 0.82) for binary classification of PPID in ponies at baseline and post-TRH; and good (ƙ = 0.73) for horses in November, but poor (ƙ = 0.40) in May. Conclusions: Limited numbers of horses with [ACTH] above threshold values. Conclusions: The assays yielded different absolute values, particularly in post-TRH samples from ponies, suggesting TRH stimulates secretion of cross-reacting peptides other than ACTH. Agreement for binary classification for PPID was moderate to good, except in basal samples from horses in May.
© 2020 EVJ Ltd.
Get Full Text
Publication Date: 2020-02-18 PubMed ID: 31955443DOI: 10.1111/evj.13227Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the differences between chemiluminescence (CL) and immunofluorescence (IF) assays in measuring Adrenocorticotropin Hormone (ACTH) in horse and pony plasma. The findings indicate significant discrepancies between the two methods, particularly after thyrotropin-releasing hormone (TRH) stimulation in ponies.

Research Methodology

  • This study compared the results of ACTH analysis using CL and IF methods.
  • Plasma ACTH levels were measured in 12 ponies, both at a basal level and following TRH stimulation, and in 45 horses’ basal samples.
  • These measurements took place in November and May for the horses, providing a seasonal comparison.

Results and Observations

  • The results showed that the CL and IF methods yielded different results, with statistical significance (P < .01).
  • For ponies, the median difference was 5.9 pg/mL at baseline and 227.9 pg/mL post TRH stimulation.
  • Additionally, for horses, the median difference was 1.9 pg/mL in November and 9.4 pg/mL in May at baseline.
  • These differences suggest that the TRH stimulation prompts the secretion of peptides that cross-react with ACTH.
  • Despite the discrepancy in absolute values, the correlation was good in ponies at baseline and in horses in November and May.
  • Bland-Altman analysis showed moderate bias and wide limits of agreement in the baseline data and large bias and wide limits in the post-TRH pony data.

Conclusions

  • Although there is a noticeable difference in the absolute values produced by the two assays, especially in the post-TRH samples sourced from ponies, the agreement for binary classification of Pituitary Pars Intermedia Dysfunction (PPID) was generally good.
  • The exception was for basal samples from horses in May, which showed poor agreement.
  • It’s suggested that the inconsistency between CL and IF assays may be due to TRH stimulation provoking the secretion of cross-reacting peptides that aren’t ACTH.
  • However, the study included a limited number of horses with ACTH above threshold values, which could affect the conclusions.

Cite This Article

APA
McGilvray TA, Knowles EJ, Harris PA, Menzies-Gow NJ. (2020). Comparison of immunofluorescence and chemiluminescence assays for measuring ACTH in equine plasma. Equine Vet J, 52(5), 709-714. https://doi.org/10.1111/evj.13227

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 52
Issue: 5
Pages: 709-714

Researcher Affiliations

McGilvray, Tegan A
  • The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, UK.
Knowles, Edward J
  • The Bell Equine Veterinary Clinic, Mereworth, Kent, UK.
Harris, Pat A
  • WALTHAM Centre for Pet Nutrition, Leicestershire, UK.
Menzies-Gow, Nicola J
  • The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, UK.

MeSH Terms

  • Adrenocorticotropic Hormone
  • Animals
  • Fluorescent Antibody Technique / veterinary
  • Horse Diseases
  • Horses
  • Luminescence
  • Luminescent Measurements / veterinary
  • Thyrotropin-Releasing Hormone

Grant Funding

  • MARS Petcare UK

References

This article includes 16 references
  1. McFarlane D, Johnson PJ, Schott HC. Pituitary pars intermedia dysfunction. In: Belknap JK, Geor R, editors. Equine laminitis. Iowa: John Wiley and Sons, Inc., 2016; p. 334-9.
  2. Rendle D. Laboratory diagnosis of the endocrine causes of laminitis. Livestock 2017;22:218-9.
  3. Irvine KL, Burt K, Hill AJ, Shaw S, Papasouliotis K. Initial analytic quality assessment and method comparison of an immunoassay for adrenocorticotropic hormone measurement in equine samples. Vet Clin Path 2016;1:154-63.
  4. Copas VEN, Durham AE. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Equine Vet J 2012;44:440-3.
  5. Adams AA, Siard MH, Reedy SE, Barker D, Elzinga S, Sanz MG. Evaluating seasonal influences on hormone responses to a diagnostic test (thyrotropin-releasing hormone stimulation) advocated for early diagnosis of pituitary pars intermedia dysfunction (PPID). Havemeyer Int. Endocr. Symp., Miami 2017; p. 12.
  6. Scott H, Andrews F, Durham A, Frank N, Hart K, Kritchevsky J. Recommendations for the diagnosis and treatment of Pituitary Pars Intermedia Dysfunction. Equine Endocrinology Group 4. 2017.
  7. Knowles EJ, Shaw S, Harris PA, Elliott J. Plasma adrenocorticotropic hormone (ACTH) concentrations in ponies measured by two different assays suggests seasonal cross-reactivity or interference. Equine Vet J 2018;50:672-7.
  8. Mcfarlane D, Paradis MR, Zimmel D, Sykes B, Brorsen BW, Sanchez A. The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and α-melanocyte-stimulating hormone plasma concentrations in horses. J Vet Intern Med 2011;25:872-81.
  9. Durham A, Shreeve H. Horse-factors influencing the seasonal increase in plasma ACTH secretion. Proceedings of Equine Endocrinology Summit with Dorothy Havemeyer Foundation, Miami, FL P. 36. 2017.
  10. Fleiss JL, Levin B, Myunghee CP. The measurement of interrater agreement. In: Fleiss J, Levin B, Myunghee CP, editors. Stat. methods rates proportions. John Wiley and Sons, Hoboken, 2003; p. 598-626.
  11. Banse HE, Schultz N, Mccue M, Geor R, McFarlane D. Comparison of two methods for measurement of equine adrenocorticotropin. J Vet Diagn Invest 2018;30:233-7.
  12. Frank N. Chapter 136 - pituitary pars intermedia dysfunction. In: Robinson NE, Sprayberry KA, editors. Robinson’s current therapy in equine medicine. 7th ed. Missouri: Elsevier Inc. 2015; p. 574-7.
  13. The Universal Protein Resource (Uniprot), accession number F6W8H2, residues 211-249. Available form: https://www.uniprot.org/blast/?about=F6W8H2[211-249]&key=Domain [cited 2019 July 15].
  14. The Universal Protein Resource (Uniprot), accession number P01189, residues 138-176. Available form: https://www.uniprot.org/blast/?about=P01189[138-176]&key=Peptide&xml:id=PRO_0000024969 [cited 2019 July 15].
  15. McFarlane D. Equine pituitary pars intermedia dysfunction. Vet Clin North Am Equine Pract 2011;27:93-113.
  16. Secombe C, Bailey S, de Laat M, Hughes K, Stewart A, Sonis J. Recommendations from the Australian and New Zealand Equine Endocrine Group and the interpretation of plasma endogenous ACTH concentrations for the diagnosis of pituitary pars intermedia dysfunction (PPID). Aust Vet J 2018;96:317-8.

Citations

This article has been cited 3 times.
  1. Drozdzewska K, Gehlen H. Markers for internal neoplasia in the horse.. Vet Med Sci 2023 Jan;9(1):132-143.
    doi: 10.1002/vms3.1042pubmed: 36495211google scholar: lookup
  2. Hinrichsen SL, Yuen KY, Dryburgh EL, Bertin FR, Stewart AJ. Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses.. Animals (Basel) 2022 Jan 28;12(3).
    doi: 10.3390/ani12030324pubmed: 35158648google scholar: lookup
  3. Thane K, Uricchio C, Frank N. Effect of early or late blood sampling on thyrotropin releasing hormone stimulation test results in horses.. J Vet Intern Med 2022 Mar;36(2):770-777.
    doi: 10.1111/jvim.16362pubmed: 35049089google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.